Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for olopatadine hydrochloride and mometasone furoate nasal spray (Ryaltris) for the symptomatic treatment of moderate to severe seasonal allergic rhinitis (SAR) and associated ocular symptoms in adults, adolescents, and children aged 6 years and older.